US 11793772
Pharmaceutical composition comprising THA as active ingredient for treating breast cancer
granted A61KA61K31/12A61K36/9066
Quick answer
US patent 11793772 (Pharmaceutical composition comprising THA as active ingredient for treating breast cancer) held by KOREA UNITED PHARM. INC. expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KOREA UNITED PHARM. INC.
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/12, A61K36/9066, A61K9/0019, A61K9/0053